Ask AI
ProCE Banner Activity

Reflections From EACS 2025: Implementing New HIV Treatment Guidelines in Latin America

Clinical Thought

The European AIDS Clinical Society (EACS) 2025 Conference reaffirmed the remarkable pace of scientific progress in HIV medicine. The release of the updated EACS HIV Treatment Guidelines stood out as a key milestone—comprehensive, evidence-based, and forward-looking.

Yet, as I listened to the presentations and panel discussions, I could not help but think about how these recommendations could, or could not, be readily implemented across Latin America.

Released: November 19, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Claudia P. Cortes, MD: consultant/advisor/speaker: Gilead/Gador, Pfizer, ViiV/GSK.